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Association between phenotype, performance with 
hearing aids, and genotype of childhood hearing loss in 
children with and without genetic alteration
Associação entre fenótipo, desempenho com próteses 
auditivas e genótipo da deficiência auditiva infantil em 
crianças com e sem alteração genética 
ABSTRACT
Purpose: To establish the frequency of genetic mutations related to sensorineural hearing loss (SNHL); to veri-
fy if there is association between the degree of SNHL and the presence of genetic alteration; and to verify if the 
Minimal Response Levels (MRL) with hearing aids vary according to the genetic alteration. Methods: Thirty 
hearing aids users with ages between 8 and 111 months were evaluated. The evaluation procedures used were: 
pure-tone audiometry; the auditory steady state response (ASSR) on sound field, with and without hearing 
aids; and genetic study of the hearing loss. Results: Three genetic mutations were diagnosed: 35delG, A1555G 
and A827G, and the children with these mutations showed higher degree of SNHL. There was no difference 
between the genetic patterns regarding the degree of SNHL, except for patients with A827G mitochondrial 
mutation, because all subjects with this mutation had profound SNHL. The difference between the MRL 
obtained with and without amplification, considering the presence of mutation and the degree of SNHL, was 
higher in children with moderate SNHL without genetic alterations, both in behavioral and electrophysiological 
evaluations. Conclusion: Genetic mutations were found in 36.7% of the sample, justifying the importance of 
genetic tracking in the hearing habilitation process. Children with genetic mutations showed higher degrees 
of hearing loss. The different mutation patterns do not directly determine the degree of hearing loss. The best 
thresholds with amplification were found in children with moderate hearing loss without genetic alterations.
RESUMO
Objetivo: Estabelecer a frequência de mutações genéticas relacionadas à deficiência auditiva neurossensorial 
(DANS); verificar se há associação entre grau da DANS e presença de alteração genética e verificar se os Ní-
veis Mínimos de Resposta (NMR) com próteses auditivas variam em função da alteração genética. Métodos: 
Foram avaliadas 30 crianças, com idades entre 8 e 111 meses, usuárias de próteses auditivas. Os procedimen-
tos de avaliação utilizados foram: audiometria tonal e resposta auditiva de estado estável (RAEE) em campo 
livre, com e sem as próteses auditivas e estudo genético da DANS. Resultados: Foram diagnosticadas três 
mutações genéticas: 35delG, A1555G e A827G, sendo que as crianças com tais mutações apresentaram maior 
grau de DANS. Não houve diferença entre os padrões genéticos em relação ao grau de DANS, com exceção 
dos pacientes com mutação mitocondrial A827G, pois todos com essa mutação eram portadores de DANS de 
grau profundo. A diferença entre os NMR obtidos sem e com o uso da amplificação, considerando a presença 
de mutação e grau de DANS, foi maior nas crianças portadoras de DANS de grau moderado sem alteração 
genética, tanto na avaliação comportamental quanto na eletrofisiológica. Conclusão: As mutações genéticas 
foram encontradas em 36,7% da amostra, o que justifica a importância do rastreamento genético no processo 
de habilitação auditiva. Crianças com mutações genéticas apresentam o maior grau de DANS. Os diferentes 
padrões de mutações não determinam diretamente o grau da DANS. Os melhores limiares com o uso da am-
plificação foram encontrados nas crianças com DANS moderada, sem alteração genética.
328 Biaggio EPV, Azevedo MF, Iório MCM, Svidnicki MCCM, Satorato EL
J Soc Bras Fonoaudiol. 2012;24(4):327-34
INTRODUCTION
In the past years improvements regarding hearing diagnosis 
practice and etiologic research of the hearing impairments 
(HI) in the pediatric population have been perceived, because 
precocious detection and intervention of hearing disorders are 
important to prevent alterations in children’s development.
Regarding the etiology of children’s hearing impairment, 
it can be classified as: acquired and genetic. The study about 
the genetic causes of HI advanced significantly and several 
genes related to this deficit have been identified(1,2). There has 
been increasing interest in studying non-syndromic recessive 
hearing impairment, mainly the GJB2gene, which codifies the 
Conexin 26 protein (Cx26), because it is responsible for most 
cases of hearing loss with genetic origin(3). 
The tracking of genetic mutation should be included in the 
battery of tests to investigate hearing impairments, because it 
helps the etiology elucidation and it enables, in cases of posi-
tivity, the genetic counseling(2). 
Moreover, the importance of knowing the diagnostic hypo-
thesis of hearing impairments is directly related to the planning 
of hearing rehabilitation.
After the establishment of the auditory diagnosis, the focus 
of the speech-language therapy is the process of selection and 
adaptation of hearing aids, even if the etiologic hypothesis is 
not established.
Some studies aim at clarifying the relationship between 
the use of hearing aids (performance and benefit), language 
development and speech perception and the different manifes-
tations of hereditary hearing impairments(4-6). Other authors(7-10) 
studied the performance of subjects with cochlear implantation, 
according to their hearing impairments, observing that children 
with genetic alterations present more benefits with cochlear 
implantation. 
Several researchers studied the relationship between 
genotype of Conexin 26 mutations and auditory phenotype 
(configuration and degree of hearing loss), considering the 
results of tonal threshold audiometry, Transient Evoked 
Otoacoustic Emission (TEOAE) and of Brainstem Auditory 
Evoked Potential (BAEP)(11,12). However, there were no found 
studies which related the findings of the research of Auditory 
Steady State Response (ASSR) and the etiology of hearing 
impairments, especially genetic.
The ASSR is an important procedure of auditory evaluation, 
because it presents more facilities and efficiency to obtain 
responses, objectivity in the register analysis, selectivity in 
the responses frequency, and higher detection of hearing res-
ponses than other objective methods such as BAEP(13). Such 
findings justify the importance of the ASSR, because young 
children may not cooperate during the behavioral auditory 
evaluation and this procedure is useful to determine the au-
ditory threshold, once there is close relationship between the 
electro physiological thresholds obtained through ASSR and 
behavioral thresholds(14).
Besides, the use of ASSR with sound field hearing aids has 
been emphasized, with the purpose of evaluating the audibility 
of weak sounds(15,16). 
It is noticed increasing interest in the genetic investigation 
of hearing impairments and of the improvement of children’s 
auditory evaluation procedures. In the same way, in the national 
scientific environment there are no clues about studies which 
relate the etiology of hearing impairments and results of ASSR 
with hearing aids in the pediatric population.
Thus, the purposes of this study were: (1) to establish the 
frequency of genetic mutations related to sensorineural hearing 
impairments in the sample; (2) to verify if there is association 
between degree of hearing loss and the presence of genetic 
alterations; and (3) to verify if the Minimum Response Levels 
(MRL) with auditory aids vary in relation to the variable ge-
netic alteration.
METHODS
This research was a clinical cross-sectional study with 
children attended at the Integrated Assistance, Research and 
Teaching Nucleus on Hearing (NIAPEA), of the Universidade 
Federal de São Paulo, with the approval of the institution›s 
Research Ethics Committee (CEP 1828/09). Parents and/or 
caretakers who agreed with their children›s participation in 
the research signed the Informed Consent Form.
The following inclusion criteria were established for this 
study: children ranging in age from 6 months to 10 years old of 
both genders; with sensorineural bilateral symmetrical hearing 
loss from mild to profound(17); users of hearing aids with bila-
teral adaptation for, at least, three months; and being inserted in 
programs of auditory stimulation (speech therapy) in a certain 
moment of the auditory habilitation process. Children who 
presented evident neurological impairments and/or associated 
deficiency, conductive impairments, asymmetrical sensori-
neural hearing loss and carriers of the auditory neuropathy 
spectrum disorder were excluded of this research.
The sample selection was performed through research at 
the NIAPEA data basis, with 552 children who were born 
between 2000 and 2009, gender part of the data basis. From 
this total, 123 children presented complete auditory evaluation 
and, considering all eligibility criteria, 58 children were found. 
It is important to emphasize that 28 children did not conclude 
all steps of the present study and, so, the sample consisted of 
30 children, male and female, with ages between eight to 111 
months old. 
The sample of 30 children presented 20 (66.7%) girls and 
10 (33.3%) boys, with ages ranging between eight and 111 
months old.
About the degree of sensorineural hearing loss (SNHL), the 
sample consisted of 12 children with severe SNHL (13.3%) and 
14 with profound SNHL (46.7%).
The auditory evaluation was performed with and without 
hearing aid through behavioral and electro physiological evalu-
ation, and also genetic study. 
The evaluation consisted of pure-tone audiometry (PTA) 
and of Auditory Steady State Response (ASSR), both in sound 
field. First, both procedures were performed without the use 
of hearing aids.
The equipment used to accomplish the audiometry in sound 
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field was an audiometer, Interacoustics®, model AC33. The 
stimuli were calibrated with proper equipment. Three different 
procedures were used to perform the free field tonal threshold 
audiometry, according to the chronological age, the develop-
ment and the children’s ability to respond sound stimuli: the 
Visual Reinforcement Audiometry (VRA); the ludic audiometry 
and the conventional audiometry.
Through these procedures, it was used the research of the 
Minimum Response Levels (MRL), minimal intensity in which 
children present responses for sound stimuli(18), in this moment 
without sound amplification. It is important to mention that, 
because this is a free field evaluation, it was obtained responses 
from the ear with better cochlear reserve. 
The MRL research was accomplished with pure modulated 
tones in the frequency warble, in the frequencies of 500 Hz, 1, 
2 and 4 kHz. The stimuli were initially presented in descending 
and after in ascending way. The sound stimuli were presented 
with maximal levels of 100 dBNA for all the frequencies. The 
protocol of this study was based on a previous one(19).
The MRLs were obtained in dBNA, but they were conver-
ted to dBNPS. Thus, the values measured from the difference 
between the dBNA in the audiometer dial and the dBNPS 
measured in the distance and positioning degree of the child in 
relation to the speaker were used. Chart 1 presents the values 
of correction obtained through frequency in different degrees 
and distances for the equipment which were used in this study.
The second auditory evaluation procedure was the ASSR, 
also performed in free field, with the equipment Smart EP by 
Intelligent Hearing System®, from a channel. The stimuli were 
calibrated in dBNPS, following the recommendations of the 
equipment manufacturer. The measurement of these stimuli 
was performed. 
The evaluations were performed in acoustically treated 
rooms, with children positioned 70 cm from the speaker and 
0° azimuth of it. All evaluations were achieved with children 
in natural sleep, regardless their age.
The evaluated ear was kept the same as the behavioral 
evaluation, because it was also a free field evaluation. The 
presentation way was ipsilateral. Besides, the same frequen-
cies were evaluated, but the maximal intensity was 90 dBNPS 
(because of speakers’ limitations).
The parameters adopted for such evaluation are displayed 
in Chart 2.
After the auditory evaluation, the MRLs were evaluated with 
the use of hearing aids. It means that the previous procedures 
were repeated (tonal audiometry and ASSR), but with children 
adapted with their hearing aids.
Before the beginning of the mentioned evaluation, it was 
verified the operation of the auditory aids and of the ear molds. 
Finally, to investigate the possibility of non-syndromic 
genetic auditory loss, a genetic study was performed. The 
collected blood was binned into a test tube with EDTA as an-
ticoagulant and it was sent to the Center of Molecular Biology 
and Genetic Engineering (CBMEG), Universidade Estadual de 
Campinas (UNICAMP). 
The DNA was extracted and analyzed through adapted 
CBMEG methods. Initially, the mutation 35delG was tracked in 
the Conexin 16 protein gene through the method allele-specific 
PCR. Next, the deletions involving the Conexin 30 (GJB6), del 
(GJB6-D13S1830) and del (GJB6-D13S1854) were analyzed 
through multiplex PCR. According to the results, the complete 
sequencing of the GJB2 gene was accomplished. 
The A1555G and A827G mitochondrial mutations were also 
analyzed in the 12S rRNA gene. The A1555G mutation was 
tracked through restriction analysis and the A827G mutation, 
through direct sequencing.
After the genetic study of the studied group, three mu-
tations were found: 35deIG, A1555G and A827G. These 
mutations were diagnosed in 11 children (36.7% of the 
sample). After this evaluation, the sample was distributed in 
two groups, according to their genetic condition: with gene-
tic alteration (n=11 children) and without genetic alteration 
(n=19 children).
Regarding the used statistical tests, to evaluate the correla-
tion between the behavioral and electro physiological MRLs in 
free field, in both studied conditions (with and without auditory 
aids), it was used the Spearman’s Correlation. Other statistical 
tests were used to analyze the data obtained in this research: 
Correlation test, Equality of Two Proportions, Wilcoxon’s, 
Kruskal-Wallis’, Mann-Whitney’s Confidence Intervals for 
the average and p-value calculation. In each hypothesis test 
it was selected the significance level of 0.05. The significant 
values were checked with an asterisk. All confidence intervals 
which were built along the study were created with 95% of 
statistical confidence. 
From the children who presented the studied genetic mu-
tations, 45% of them presented the 35deIG mutation, 22% the 
A1555G mutation and 33% the A827G mutation. 
Chart 1. Difference in dB by frequency and azimuth to convert dBNA 
in dBNPS
500 Hz 1 kHz 2 kHz 4 kHz
0º azimuth +8.6 dB -3.9 dB -6.5 dB -10.9 dB
Chart 2. Research parameters of the ASSR
Carriers frequencies: 500 Hz, 1 kHz, 2 kHz e 4 kHz
Modulator frequencies: left ear – 77, 85, 93 and 101 Hz
                       right ear – 79, 87, 95, 103 Hz
Stimuli: tone pips (brief tones with short duration)
Electrodes and assembly: negative electrode in the tested ear; ground 
electrode in the not tested ear and positive electrode in the front
Impedance lower than 3 kohm
Amplifications and filters: amplification of 100,000 times, with high-
pass filter of 30 Hz and low-pass filter of 300 Hz
Average out: until 600 for each intensity, with sweeping in every 20
Presented intensities in descending order, with range of 10 dBNPS, 
in order to detect the electro physiologic auditory threshold
Beginning intensity: 20 dB above the behavioral threshold
Responses detection: statistical technique F
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The HI degree in both groups, with and without genetic 
alteration, is presented in Table 1.
It was noticed that in the sample group, with genetic alte-
ration, the SNHL degree which was the most prevalent was 
the profound degree, 63.6% (7/11), with significant difference. 
It was accomplished an analysis of the group of children 
with genetic alterations, considering the distribution of SNHL 
degree for the three main studied genetic mutations: 35deIG, 
A1555G and A827G. There was no significant difference be-
tween the heterozygote (p=0.248) and homozygote (p=0.157) 
patterns of the 35delG mutation in relation to the SNHL degree.
There was also no significant difference between the SNHL 
degrees for the patients with A1555G mitochondrial mutation. 
There was significant difference among the SNHL degrees for 
the patients with A827G mitochondrial mutation, and all the 
patients with this mutation were carriers of profound degree 
SHNLs.
After that, the MRLs obtained on both procedures with and 
without the use of amplification were evaluated, considering 
the following variables: group and degree of loss (Tables 2, 
3, 4 and 5).
As great part of the sample is profound degree SNHL 
carrier, there were many absent MRLs in both procedures 
(behavioral and electro physiological evaluations). In these 
cases, as it was not obtained information, it was not possible to 
perform the analysis. To show this MRL absence, the symbol 
“-x-“ was inserted. 
DISCUSSION
The sample consisted of 30 children with sensorineural 
hearing loss, moderate and profound level, with ages ranging 
between 8 months and 9 years old, users of hearing aids, treated 
at NIAPEA.
The children’s distribution, according to the variable degree 
of auditory deficiency, evidenced that the highest degree of 
occurrence was the profound, followed by the moderate and 
the severe. Some authors(20) who elaborated a study with the 
purpose of describing the auditory characteristics of children 
seen by a Hearing Health Program, similar to the NIAPEA, 
observed that 46% of the children presented profound hearing 
loss, very similar to the present study.
It was accomplished genetic tracking to investigate the main 
recessive non-syndromic genetic mutations. The mutations 
35delG, A1555G and A827G were diagnosed. From a total of 
30 children, 19 (63.3%) did not present any genetic mutation 
and 11 (36.7%) presented some type of genetic mutation
In the group formed by children with genetic alteration, 
it is emphasized the presence of two siblings, who presented 
the same genetic mutation (35delG in heterozygosis). This is 
a frequently data related by literature, because in these cases 
the authors consider the family, not the individual. These 
siblings present the same genetic information, but the two 
subjects were considered, because one of the concerns of this 
study was relating genotype and phenotype. It is important to 
mention that they presented different performances regarding 
the use of hearing aids.
The focus of the genetic tracking was the study of reces-
sive mutations, because among the heredity, the autosomal 
recessive is the most frequent(21). Another important aspect is 
the 35delG mutation, because it is the most frequent SNHL 
cause(1). Summarizing, the HI physiopathological extract caused 
as a consequence of the 35ddelG is related to alterations in 
the functioning of the gap junctions and in the maintenance of 
high concentrations of intracellular potassium, which damage 
the mechanism of fast response by the ciliated cells to the new 
sound stimuli and, so, it results in hearing impairments(22,23). 
Considering the results of different studies performed in 
Brazil, it is observed great variation in relation to the pro-
portion of the 35delG mutation, ranging from 5.3%(2) to 45% 
of the sample which presents the mutations (present study). 
This finding may be justified by the significant miscegenation 
in Brazil. The Brazilian population presents interaction of 
different races and ethnics, mainly the genetic integration of 
Europeans, especially from Italy, Spain and Portugal. Another 
researched genetic alteration was the A1555G, because it is 
the most frequent deoxyribonucleic acid (DNA) mutation, 
associated with higher sensibility to ototoxic drugs, especially 
the use of amino glycosides(24). In the group of children with 
genetic alterations, two of them were carriers of this type of 
mutation, what represents 22% of the sample. 
As the mitochondrial mutation A1555G, the mutation 
A827G, in the 12S rRNA gene, was initially associated with 
hearing loss susceptibility induced by amino glycosides(25). 
Also, 33% of the children from the group with genetic alte-
rations presented this mitochondrial mutation. However, the 
effect of this alteration is still controversial. Some authors 
believe that this mutation is simple polymorphism, not justified 
by the hearing loss in individuals who present this alteration.
It was also studied the children’s degree of SNHL, consi-
dering the distribution of the sample in two groups: with and 
without genetic alteration (Table 1). The results evidenced 
that in the group of children with genetic alteration there was 
predomination of profound degree SNHL (63.6%). In the group 
of children without genetic alteration there was no significant 
difference among the three SNHLs degrees (moderate, severe 
and profound).
Several studies describe the auditory characteristics related 
to SNHLs with recessive genetic origin, that, in most cases, 
are characterized by severe and profound degree auditory de-
ficiency, but in some cases the degree of hearing loss may be 
moderate(4,24,26), as it was observed in the present study. 
Then, it was analyzed the group of children with genetic 
Table 1. Sample distribution according to the variable SNHL degree in 
the groups with and without genetic alteration
SNHL 
degree
With genetic alteration Without genetic alteration
n % n %
Moderate 4 3.,4 8 42.1
Severe 0 0 4 21.1
Profound 7 63.6 7 36.8
Total 11 100 19 100
Note: SNHL = sensorineural hearing loss
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Table 2. Comparison of the behavioral MRL (dBNPS) with and without hearing aid, in the group without genetic alteration, considering the variable 
SNHL degree
Audiometry Mean Median SD Q1 Q3 n CI p-value
Moderate
500 Hz
Without HA 67.1 71.1 16.8 52.2 79.4 8 11.6
0.011*
With HA 43.4 45.8 11.2 35.7 53.2 8 7.8
1 kHz
Without HA 64.3 68.6 11.9 54.9 71.1 8 8.3
0.011*
With HA 36.1 33.7 14.2 26.1 41.1 8 9.8
2 kHz
Without HA 65.9 66.0 10.7 58.5 70.8 8 7.4
0.012*
With HA 38.4 34.3 15.2 32.3 43.9 8 10.5
4 kHz
Without HA 65.2 65 11.3 59.1 69.6 7 8.4
0.026*
With HA 44.4 39.1 24.5 28.5 56 8 17
Profound
500 Hz
Without HA 90.4 91.8 5.8 85.2 93.6 6 4.7
0.027*
With HA 61.9 63.6 1.2 53.3 65.8 7 10.5
1 kHz
Without HA 84.4 86.1 12.6 78.6 91.1 3 14.2
0.109
With HA 54 51.1 19.2 43.6 61.2 7 14.2
2 kHz
Without HA 78.5 78.5 21.2 71 86 2 29.4
0.180
With HA 62 58.5 23.7 51 80 7 17.6
4 kHz
Without HA 81.1 81.1 9.9 77.6 84.6 2 13.7
0.180
With HA 47.4 49.1 1.6 41.6 54.1 3 14.2
Severe
500 Hz
Without HA 82.1 83.3 6.1 80.7 84.7 4 5.9
0.066
With HA 53.3 55.8 10.5 49.9 59.3 4 10.3
1 kHz
Without HA 77.4 78.7 8.6 73.6 82.5 4 8.4
0.066
With HA 47.4 48.7 12.5 42.4 53.7 4 12.3
2 kHz
Without HA 78 76.8 9.3 72.3 82.5 4 9.1
0.066
With HA 44.3 49.3 14.5 39.6 53.9 4 14.2
4 kHz
Without HA 79.6 79.6 13.4 71.6 87.5 4 13.1
0.068
With HA 62.1 57.1 17 49.1 70 4 16.7
* Significant values (p≤0.05) – Wilcoxon’s test
Note: SD = standard deviation; Q1 = 1st quartile; Q3 = 3rd quartile; CI = confidence interval; SNHL = sensorineural hearing loss; HA = hearing aid; MRL = Minimum 
Response Levels
Table 3. Comparison of the behavioral MRL (dBNPS) with and without hearing aid, in the group with genetic alteration, considering the variable 
SNHL degree
Audiometry Mean Median SD Q1 Q3 n CI p-value
Moderate
500 Hz
Without HA 69.7 71.1 8.3 66.1 74.7 4 8.2
0.066
With HA 46 48.3 4.9 45.7 48.6 4 4.8
1 kHz
Without HA 64.9 68.6 17.1 59.8 73.6 4 16.8
0.068
With HA 36.2 38.7 7.1 33.6 41.2 4 7
2 kHz
Without HA 65.2 63.5 12.6 58.5 71 3 14.2
0.102
With HA 36.4 36.8 6.7 32.3 40.9 4 6.6
4 kHz
Without HA 60.7 59 22.6 49 71.6 3 25.6
0.109
With HA 41.8 39.6 20.9 31 50.4 4 20.5
Profound
500 Hz
Without HA 90.3 91.1 6.1 84.9 93.6 6 4.8
0.027*
With HA 60.7 58.6 11.4 53.6 70.8 7 8.5
1 kHz
Without HA 89.4 93.6 8.8 83.6 96.1 6 7
0.026*
With HA 51.1 51.1 15.8 38.6 56.1 7 11.7
2 kHz
Without HA 87.3 91 9.5 84.8 93.5 4 9.3
0.066
With HA 55.1 53.5 13.4 53.5 63.5 7 9.9
4 kHz
Without HA 81.6 79.1 5 79.1 81.6 4 4.9
0.066
With HA 58.4 61.6 13.8 55.4 64.1 6 11
* Significant values (p≤0.05) – Wilcoxon’s test
Note: SD = standard deviation; Q1 = 1st quartile; Q3 = 3rd quartile; CI = confidence interval; SNHL = sensorineural hearing loss; HA = hearing aid; MRL = Minimum 
Response Levels
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Table 4. Comparison of the electrophysiologic MRL (dBNPS) with and without hearing aid, in the group without genetic alteration, considering the 
variable SNHL degree
ASSR Mean Median SD Q1 Q3 n CI p-value
Moderate
500 Hz
Without HA 67.9 65 8.6 62.5 70 7 6.4
0.017*
With HA 45.7 40 7.9 40 50 7 5.8
1 kHz
Without HA 71.9 72.5 14.6 60 82.5 8 10.1
0.011*
With HA 41.3 35 14.6 30 50 8 10.1
2 kHz
Without HA 77.5 80 11.3 73.8 82.5 8 7.9
0.011*
With HA 45.6 45 14 35 56.3 8 9.7
4 kHz
Without HA 74.3 80 14.3 72.5 80 7 10.6
0.018*
With HA 55.6 55 18.8 40 67.5 8 13
Profound
500 Hz
Without HA - x - - x - - x - - x - - x - 0 - x -
- x -
With HA 67 60 14 60 70 5 12.2
1 kHz
Without HA 90 90 - x - 90 90 1 - x -
- x -
With HA 58.6 55 15.7 47.5 62.5 7 11.7
2 kHz
Without HA 90 90 - x - 90 90 1 - x -
- x -
With HA 65 60 15.8 55 72.5 7 11.7
4 kHz
Without HA - x - - x - - x - - x - - x - 0 - x -
- x -
With HA 66 60 15.2 60 70 5 13.3
Severe
500 Hz
Without HA 83.8 82.5 4.8 80 86.3 4 4.7
0.066
With HA 52.5 52.5 6.5 48.8 56.3 4 6.3
1 kHz
Without HA 85 85 5 82.5 87.5 3 5.7
0.102
With HA 53.8 55 7.5 48.8 60 4 7.3
2 kHz
Without HA 87.5 87.5 3.5 86.3 88.8 2 4.9
0.180
With HA 57.5 60 9.6 52.5 65 4 9.4
4 kHz
Without HA 85 85 5 82.5 87.5 3 5.7
0.109
With HA 60 55 14.1 50 65 4 13.9
* Significant values (p≤0.05) –Wilcoxon’s test
Note: SD = standard deviation; Q1 = 1st quartile; Q3 = 3rd quartile; CI = Confidence Interval; SNHL = sensorineural hearing loss; HA = hearing aid; MRL = Minimum 
Response Levels; ASSR = Auditory Steady State Response
Table 5. Comparison of the electro physiologic MRL (dBNPS) with and without hearing aid, in the group with genetic alteration, considering the 
variable SNHL degree
ASSR Average Median SD Q1 Q3 n CI p-value
Moderate
500 Hz
Without HA 80 82.5 12.2 72.5 90 4 12
0.066
With HA 52.5 52.5 2.9 50 55 4 2.8
1 kHz
Without HA 78.3 75 10.4 72.5 82.5 3 11.8
0.102
With HA 47.5 47.5 6.5 43.8 51.3 4 6.3
2 kHz
Without HA 75 75 1 70 80 3 11.3
0.109
With HA 43.8 42.5 8.5 38.8 47.5 4 8.4
4 kHz
Without HA 76.7 75 12.6 70 82.5 3 14.2
0.102
With HA 51.3 47.5 14.4 40 58.8 4 14.1
Profound
500 Hz
Without HA 90 90 - x - 90 90 1 - x -
- x -
With HA 70 70 14.1 60 80 7 10.5
1 kHz
Without HA 90 90 - x - 90 90 1 - x -
- x -
With HA 60.7 60 11.3 55 60 7 8.4
2 kHz
Without HA - x - - x - - x - - x - - x - 0 - x -
- x -
With HA 65.7 65 5.3 62.5 67.5 7 4
4 kHz
Without HA - x - - x - - x - - x - - x - 0 - x -
- x -
Without HA 75.7 75.0 4.5 72.5 80 7 3.3
Wilcoxon’s test (p≤0,05)
Note: SD = standard deviation; Q1 = 1st quartile; Q3 = 3rd quartile; CI = confidence interval; SNHL = sensorineural hearing loss; HA = hearing aid; MRL = Minimum 
Response Levels; ASSR = Auditory Steady State Response
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alteration, considering the distribution of the SNHL degree for 
the three main studied genetic mutations: 35deIG, A1555G 
and A827G.
In the children with the 35delG mutation, there was no sig-
nificant difference between the heterozygote and homozygote 
patterns of the 35delG mutation in relation to the degree of 
SNHL. The issue heterozygote and homozygote if often studied 
by researchers(1,9). The authors refer that it is necessary that the 
individual inherits two mutated alleles, one from the father and 
another from the mother, to express the auditory deficiency 
(homozygosis). Thus, it is impossible to the Conexin 26 to be 
codified by the altered GJB2 gene, what would cause the SHNL. 
When the child presents the 35delG mutation in heterozygosis, 
it means that there is mutation in only one of the alleles, and 
it is possible that the other allele codifies the protein. It would 
imply in a lower number of codified Conexin 26. So, the 35delG 
mutation in heterozygosis does not diagnosis cause of deafness. 
It only proves that the patient is carrier of this mutation. 
There was no significant difference among the SNHL de-
grees for the patients with A1555G mitochondrial mutation. 
An author(27) refers that the auditory phenotype, in subjects 
who are carriers of the A1555G mitochondrial mutation, may 
vary even among members of the same family, and the degree 
of the SNHL may be moderate and profound.
There was significant difference among the degrees of 
SNHL for the patients with the A827G mitochondrial mutation, 
and all patients with this mutation were carriers of profound 
degree SNHL. However, other authors(25) mention that the de-
gree of the hearing deficiency may be from mild to profound. 
According to the same authors, aggravating factors for the 
deficiency would be the time of use of amino glycosides, the 
associated use of this drug, the age of children when they use 
amino glycosides, etc. 
The MRLs obtained in the procedures with and without 
the use of amplification were also evaluated, considering the 
following variables: group and HI degree (Tables 2, 3, 4 and 
5). In these analysis, the data which deserves more relevance 
is the fact that only the children with severe degree of SNHL, 
without genetic alteration, as in the behavioral as in the electro 
physical evaluation, presented significant difference between 
the evaluations with and without hearing aids.
Some authors studied the relationship among the use of 
auditory aids (performance and benefit), language development 
and speech perception with different manifestations of HI with 
genetic origin(4-6). The results of the three mentioned studies 
converge to a similar finding, that the genetic mutations do 
not determine directly the benefit with sound amplification. 
Nevertheless, the highest incidence of more severe SNHLs 
in children with genetic mutations, leads to a negative impact 
about the benefits of hearing aids for these children. The au-
thors emphasized that the linguistic and hearing performance 
would be correlated with the SNHL severity, age of diagnosis 
and intervention, quality of the speech-language therapy, etc.
The findings of the present study, in children without ge-
netic alteration, agree with the previously mentioned authors, 
because the children who presented significant MRL difference, 
with and without sound amplification, are carriers of moderate 
degree SNHL. However, the children with genetic alteration, 
even with moderate HI, do not present significant differences, 
only a tendency of it that could perhaps be significant if the 
sample was higher. The greatest benefit with the hearing aids 
would be related to the lowest cochlear impairments.
Another possible hypothesis for this finding is the MRL 
absence, mainly in the condition without hearing aids, once the 
children with severe and profound SNHL present high index of 
absent responses in the maximum level of the sound pressure 
which was evaluated. The maximum level in which the electro 
physical MRL was researched was 90 dBNPS, because of a 
limitation of loudspeakers. Maybe if it was higher and if it was 
obtained higher number of present MRL, a more conclusive 
analysis could be achieved.
The Idea of relating the genetic HI manifestations with the 
auditory performance with the use of cochlear implant (CI) 
is also a concern of many researchers(7-10). Different from the 
findings with hearing aids, the children with genetic mutations 
present, in general, higher benefits with the CI when compared 
with the children without such mutations. It would happen 
because the SNHL caused by the Cx26 mutations cause alte-
ration which do not affect cells of the spiral ganglion, which 
are the neural elements stimulated by the implant, leading to 
better results. So, in implanted patients the genetic etiology 
would be a positive indicator of success in the linguistic and 
auditory performance. 
CONCLUSION
The data analysis allowed the conclusion that the genetic 
mutations were found in 11 children (36.7%) of the sample. 
They presented three diagnosed mutations: 35delG, A1555G 
and A827G. In addition, the children with the studied genetic 
alterations presented higher degree of SNHL. It is also conclu-
ded that the behavioral and electro physical MRLs of children 
with moderate degree SNHL, without genetic alteration were 
lower than the MRLs of children with genetic alteration, also 
carriers of moderate degree SNHL, what means better perfor-
mance with aids by children without genetic alteration 
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